Cancellation of publicly held Actelion shares and delisting from SIX Swiss Exchange as of November 7, 2017
October 31, 2017 02:02 ET
|
Actelion Pharmaceuticals Ltd
ALLSCHWIL/BASEL, SWITZERLAND - October 31, 2017 - By decision dated October 25, 2017, the Cantonal Court of the Canton of Basel-Landschaft cancelled all publicly held registered shares of Actelion Ltd...
Cancellation of publicly held Actelion shares and delisting from SIX Swiss Exchange as of November 7, 2017
October 31, 2017 02:02 ET
|
Actelion Pharmaceuticals Ltd
ALLSCHWIL/BASEL, SWITZERLAND - October 31, 2017 - By decision dated October 25, 2017, the Cantonal Court of the Canton of Basel-Landschaft cancelled all publicly held registered shares of Actelion Ltd...
Befreiung von Publizitätspflichten zur Aufrechterhaltung der Kotierung
June 30, 2017 01:02 ET
|
Actelion Pharmaceuticals Ltd
ALLSCHWIL/BASEL, SCHWEIZ - 30. Juni 2017 - Am 16. Februar 2017 hat Janssen Holding GmbH, eine Tochtergesellschaft von Johnson & Johnson (NYSE:JNJ), den Angebotsprospekt zum öffentlichen...
Befreiung von Publizitätspflichten zur Aufrechterhaltung der Kotierung
June 30, 2017 01:02 ET
|
Actelion Pharmaceuticals Ltd
ALLSCHWIL/BASEL, SCHWEIZ - 30. Juni 2017 - Am 16. Februar 2017 hat Janssen Holding GmbH, eine Tochtergesellschaft von Johnson & Johnson (NYSE:JNJ), den Angebotsprospekt zum öffentlichen...
Johnson & Johnson Completes Acquisition of Actelion
June 16, 2017 01:01 ET
|
Actelion Pharmaceuticals Ltd
ALLSCHWIL/BASEL, SWITZERLAND - 16 June 2017 - Actelion Ltd (SIX: ATLN) today announced the completion of the acquisition of Actelion Ltd by Johnson & Johnson for a total purchase price of...
Johnson & Johnson Completes Acquisition of Actelion
June 16, 2017 01:01 ET
|
Actelion Pharmaceuticals Ltd
ALLSCHWIL/BASEL, SWITZERLAND - 16 June 2017 - Actelion Ltd (SIX: ATLN) today announced the completion of the acquisition of Actelion Ltd by Johnson & Johnson for a total purchase price of...
Actelion announces changes to its executive team upon completion of the transaction with Johnson & Johnson
June 14, 2017 11:36 ET
|
Actelion Pharmaceuticals Ltd
ALLSCHWIL/BASEL, SWITZERLAND - 14 June 2017 - Actelion Ltd (SIX: ATLN) today announced changes to its executive team that will take effect upon the settlement of the public tender offer by Johnson...
Actelion announces changes to its executive team upon completion of the transaction with Johnson & Johnson
June 14, 2017 11:36 ET
|
Actelion Pharmaceuticals Ltd
ALLSCHWIL/BASEL, SWITZERLAND - 14 June 2017 - Actelion Ltd (SIX: ATLN) today announced changes to its executive team that will take effect upon the settlement of the public tender offer by Johnson...
Publication of Idorsia's prospectus relating to the listing of Idorsia Ltd on SIX Swiss Exchange
June 09, 2017 11:46 ET
|
Actelion Pharmaceuticals Ltd
ALLSCHWIL/BASEL, SWITZERLAND - 09 June 2017 - Actelion Ltd (SIX:ATLN) today published the listing prospectus relating to the listing of Idorsia shares on SIX Swiss Exchange. With the tender offer for...
Publication of Idorsia's prospectus relating to the listing of Idorsia Ltd on SIX Swiss Exchange
June 09, 2017 11:46 ET
|
Actelion Pharmaceuticals Ltd
ALLSCHWIL/BASEL, SWITZERLAND - 09 June 2017 - Actelion Ltd (SIX:ATLN) today published the listing prospectus relating to the listing of Idorsia shares on SIX Swiss Exchange. With the tender offer for...